Discovery of immunopotentiatory drugs: current and future strategies
Author:
Affiliation:
1. Department of Gene and Protein Therapeutics, Glaxo Smith Kline Research and Development, Medicines Research Centre, Stevenage, UK
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Link
https://academic.oup.com/cei/article-pdf/130/3/363/42141300/j.1365-2249.2002.02016.x.pdf
Reference54 articles.
1. Immunomodulatory agents for the prophylaxis and therapy of infections;Masihi;Int J Antimicrob Agents,2000
2. Imiquimod applied topically. a novel class of immune response modifier and new class of drug;Miller;Int J Immunopharm,1999
3. Imiquimod and Resiquimod as novel immunomodulators;Dockrell;J Antimicrob Chemother,2001
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs;Journal of Medicinal Chemistry;2023-09-06
2. X-ray crystallography and sickle cell disease drug discovery—a tribute to Donald Abraham;Frontiers in Molecular Biosciences;2023-05-24
3. Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property;Expert Opinion on Therapeutic Patents;2021-11-01
4. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants;Trends in Pharmacological Sciences;2018-06
5. Formulation and in vitro stability evaluation of ethosomal carbomer hydrogel for transdermal vaccine delivery;Colloids and Surfaces B: Biointerfaces;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3